Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a common eye drop gel speed up wound healing?

NCT ID NCT03452072

First seen May 26, 2026 · Last updated Jun 22, 2026 · Updated 4 times

Summary

This study tested whether applying timolol gel (a drug usually used for glaucoma) to small surgical wounds after skin cancer removal helps them heal faster and look better. Researchers compared timolol gel to plain Vaseline in 87 adults with wounds up to 1.5 cm. The main goal was to see if more wounds were fully healed by 30 days with timolol, and to check for any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Mohs and Dermatologic Surgery Center, Brigham and Women's Hospital

    Boston, Massachusetts, 02130, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

timolol gel

What this could lead to

If it works, this could offer a simple, low-cost way to speed up healing of small surgical wounds and improve scar appearance.

What could go wrong

This is a small, early-phase study with only 87 participants. The effect may be modest, and timolol can cause side effects like skin irritation or, rarely, heart or lung issues.

Conditions

The condition(s) this trial relates to.

skin cancer Surgical Wound

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.